Multihance Versus Magnevist in Breast MRI

NCT00486473 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Multihance
DRUG: Magnevist

Sponsor

Bracco Diagnostics, Inc